Alzheimer's Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Integration of transcriptome data with protein-protein and transcriptional regulatory interactions resulted with central (hub) proteins (UBA52, RAC1, CREBBP, AR, RPS11, SMAD3, RPS6, RPL12, RPL15, and UBC), regulatory transcription factors (FOXC1, GATA2, YY1, FOXL1, NFIC, E2F1, USF2, SRF, PPARG, and JUN) and microRNAs (mir-335-5p, mir-26b-5p, mir-93-5p, mir-124-3p, mir-17-5p, mir-16-5p, mir-20a-5p, mir-92a-3p, mir-106b-5p, and mir-192-5p) as key signaling and regulatory molecules associated with transcriptional changes for the AD.
|
30606694 |
2019 |
Malignant tumor of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these results indicate that RPL15 is involved in human colon carcinogenesis and might be a potential clinical biomarker and/or target for colon cancer therapy.
|
31523176 |
2019 |
Colon Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Together, these results indicate that RPL15 is involved in human colon carcinogenesis and might be a potential clinical biomarker and/or target for colon cancer therapy.
|
31523176 |
2019 |
Idiopathic pulmonary arterial hypertension
|
0.010 |
Biomarker
|
disease |
BEFREE |
Four mostly affected proteins (RPL15, Cathepsin S, Histone H3.3 and HMGB1) were experimentially validated which belonged to ribosome pathway, oxidative phosphorylation pathway, systemic lupus erythematosus pathway, complement and coagulation cascades pathway, whose modifications and modulations mostly accounted for therapeutic capacity of this compound against PAH.
|
29615702 |
2018 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Mutations in the ribosomal protein Rpl10 (uL16) can be drivers of T-cell acute lymphoblastic leukemia (T-ALL).
|
28715419 |
2017 |
leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further studies are warranted to verify the feasibility via targeting AURKB/p70S6K/RPL15 axis for leukemia therapy.
|
27612557 |
2016 |
Childhood Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Further studies are warranted to verify the feasibility via targeting AURKB/p70S6K/RPL15 axis for leukemia therapy.
|
27612557 |
2016 |
Tumor Progression
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
|
26498693 |
2015 |
Acute respiratory infections
|
0.010 |
Biomarker
|
group |
BEFREE |
In summary, this study suggests RPL6, RPL3, and RPL15 as hub genes and the ribosome pathway to be significantly associated with viral ARI in infants, which might also be used as potential markers for the viral etiology.
|
26782481 |
2015 |
Tumor Cell Invasion
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
The high expression of RPL15 was inversely correlated with TNM stage, histological differentiation, T classification and vascular invasion.
|
26498693 |
2015 |
Pancreatic Ductal Adenocarcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
|
26498693 |
2015 |
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Low expression of RPL15 was significantly associated with poor overall survival of PDAC patients.
|
26498693 |
2015 |
Malignant neoplasm of skin
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The genes CNN2, COX4I1, COX5B, COX7C, CRLF3, CTSC, NDRG1, and LMNA showed increased expression in skin cancer (p < 0.02), while RPL15 and LGTN were down-regulated (p < 0.03).
|
16865251 |
2006 |
Esophageal Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
All these data suggested that EC45, encoding ribosomal protein L15 and overexpressing in esophageal cancer might play a possible role in carcinogenesis of esophagus.
|
11223259 |
2001 |
Esophageal carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
All these data suggested that EC45, encoding ribosomal protein L15 and overexpressing in esophageal cancer might play a possible role in carcinogenesis of esophagus.
|
11223259 |
2001 |
Malignant neoplasm of esophagus
|
0.010 |
Biomarker
|
disease |
BEFREE |
All these data suggested that EC45, encoding ribosomal protein L15 and overexpressing in esophageal cancer might play a possible role in carcinogenesis of esophagus.
|
11223259 |
2001 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Together, these results indicate that RPL15 is involved in human colon carcinogenesis and might be a potential clinical biomarker and/or target for colon cancer therapy.
|
31523176 |
2019 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
However, little is known about the role of RPL15 in PDAC carcinogenesis and progression.
|
26498693 |
2015 |
Carcinogenesis
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
All these data suggested that EC45, encoding ribosomal protein L15 and overexpressing in esophageal cancer might play a possible role in carcinogenesis of esophagus.
|
11223259 |
2001 |
Intelligence
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A combined analysis of genetically correlated traits identifies 187 loci and a role for neurogenesis and myelination in intelligence.
|
29326435 |
2019 |
Anemia, Macrocytic
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cardiac Arrhythmia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Fatigue
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|